9:00Introduzione del Corso
9:20The spectrum of aorta and aortic valve diseases in the young
9:40Natural histories of bicuspid aortic valve
10:00Genetics of aortic diseases: work in progress
Discussion with Marco Marconi, Paolo Ortolani
10:20Anatomy and pathology of the aorta. What cardiologists and cardiac surgeons cannot ignore
10:40Defining mechanisms and progression of aortic valve insufficiency in tricuspid and bicuspid valves
Ruggero De Paulis
11:00Integrated imaging of the aortic valve and of the aorta
Discussion with Marcello Galvani, Andrea Rubboli
11:30New ESC/EACTS guidelines on the treatment of aortic valve disease with particular focus on young adults
11:50Mechanical aortic valve prosthesis in young adults: is it still a real therapeutic option despite guidelines?
12:10The new generation aortic valve bioprostheses, evidences and perspectives
Discussion with Alberto Tripodi, Giuseppe Speziale
14:00Aortic valve repair: when and how
14:20The aortic valve reconstruction with the Ozaki technique: the game changer?
14:40The Ross procedure: what are the limitations? Is it time for a hard look at current practices?
Discussion with Giancarlo Piovaccari, Enrico Coscioni
Alberto Albertini, Claudio Rapezzi
Aortic valve pathology in the age group between 18 and 65 years represents 20% of the total aortic valvulopathies, in this age group congenital and genetic aspects prevail over purely degenerative ones. The ideal aortic valve substitute for young adults requiring aortic valve replacement remains elusive.
Young and middle-aged patients have a longer anticipated life expectancy and a higher level of physical activity than their elderly counterparts. In recent years, there has been a growing focus on long-term outcomes following aortic valve replacement in this specific patient population.
The direct impact of the choice of prosthesis on long-term survival, quality of life and rates of valve-related complications in younger adults is still controversial. Although conventional aortic valve replacement using a biological or mechanical prosthesis significantly improve the natural history of the disease, in this scenario there are aspects that need to be explored in light of the latest knowledge on young’s aortic valve and aorta diseases and of the latest technical innovations on their treatment.